BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 6113872)

  • 21. Effects of aging and morphine administration on calmodulin and calmodulin-regulated enzymes in striata of mice.
    Hoskins B; Ho IK; Meydrech EF
    J Neurochem; 1985 Apr; 44(4):1069-73. PubMed ID: 2857771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA; Prishchepa LA; Kurskiĭ MD
    Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ
    Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle.
    Pizarro M; Puente J; Sapag-Hagar M
    FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibitory effect of regucalcin on Ca2+/calmodulin-dependent cyclic AMP phosphodiesterase activity in rat kidney cytosol.
    Yamaguchi M; Kurota H
    Mol Cell Biochem; 1997 Dec; 177(1-2):209-14. PubMed ID: 9450664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
    Crimaldi AA; Kuo IC; Coffee CJ
    Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclic nucleotide phosphodiesterase in rat parotid gland.
    Yokoyama N; Abe M; Furuyama S
    Can J Physiol Pharmacol; 1981 Mar; 59(3):293-9. PubMed ID: 6261905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenylate cyclase and cyclic nucleotide phosphodiesterases in the developing rat liver.
    Sicard RE; Aprille JR
    Biochim Biophys Acta; 1977 Dec; 500(2):235-45. PubMed ID: 201294
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
    Liao CH; Tzeng CC; Teng CM
    Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of a calmodulin-dependent high-affinity cyclic AMP and cyclic GMP phosphodiesterase from male mouse germ cells.
    Geremia R; Rossi P; Mocini D; Pezzotti R; Conti M
    Biochem J; 1984 Feb; 217(3):693-700. PubMed ID: 6324744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone induces a calmodulin-dependent alteration in phosphodiesterase activity of rat kidney in vivo.
    Marcus R; Grant BF
    Endocrinology; 1983 Mar; 112(3):1065-9. PubMed ID: 6295744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation by a beta-adrenergic receptor of a Ca2+-independent adenosine 3',5'-(cyclic)monophosphate phosphodiesterase in C6 glioma cells.
    Onali P; Schwartz JP; Hanbauer I; Costa E
    Biochim Biophys Acta; 1981 Jul; 675(2):285-92. PubMed ID: 6268187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
    Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
    Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of calmodulin by local anesthetics, mepacrine, and propranolol.
    Volpi M; Sha'afi RI; Epstein PM; Andrenyak D; Feinstein MB
    Ann N Y Acad Sci; 1980; 356():441-2. PubMed ID: 6263163
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulation of cyclic nucleotide phosphodiesterase by products of phosphatidylinositol metabolism catalyzed by phospholipase A2.
    Tai HH; Tai CL
    Arch Biochem Biophys; 1982 Apr; 214(2):622-7. PubMed ID: 6284032
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of somatostatin and dopaminergic agents on bovine pituitary phosphodiesterase activity.
    Nagasaka A; Hidaka H; Nakagawa H; Nakai A; Ohyama T; Aono T; Masunaga R; Iwase K
    Neuroendocrinology; 1986; 43(3):410-5. PubMed ID: 2874515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ontogenetic changes in adenylate cyclase, cyclic AMP phosphodiesterase and calmodulin in chick ventricular myocardium.
    Epstein PM; Andrenyak DM; Smith CJ; Pappano AJ
    Biochem J; 1987 Apr; 243(2):525-31. PubMed ID: 2820384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The subcellular localization of calmodulin, cyclic AMP phosphodiesterase, and adenylate cyclase in bovine adrenal medulla.
    Tirrell JG; Coffee CJ
    Arch Biochem Biophys; 1983 Apr; 222(2):380-8. PubMed ID: 6303221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of bovine brain calmodulin on calmodulin-dependent stimulation of plasma membrane-bound guanylate cyclase in Tetrahymena pyriformis.
    Kudo S; Muto Y; Nagao S; Nozawa Y
    Biochem Int; 1983 Sep; 7(3):361-7. PubMed ID: 6148080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.